| Final results of the 94–01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced … F Denis, P Garaud, E Bardet, M Alfonsi, C Sire, T Germain, P Bergerot, ... Journal of clinical oncology 22 (1), 69-76, 2004 | 863 | 2004 |
| Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT … F Denis, P Garaud, E Bardet, M Alfonsi, C Sire, T Germain, P Bergerot, ... International Journal of Radiation Oncology* Biology* Physics 55 (1), 93-98, 2003 | 258 | 2003 |
| Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study MC Garassino, BC Cho, JH Kim, J Mazières, J Vansteenkiste, H Lena, ... The Lancet Oncology 19 (4), 521-536, 2018 | 176 | 2018 |
| Randomized trial comparing a web-mediated follow-up with routine surveillance in lung cancer patients F Denis, C Lethrosne, N Pourel, O Molinier, Y Pointreau, J Domont, ... JNCI: Journal of the National Cancer Institute 109 (9), 2017 | 131 | 2017 |
| Sensitization by dietary docosahexaenoic acid of rat mammary carcinoma to anthracycline: a role for tumor vascularization S Colas, K Mahéo, F Denis, C Goupille, C Hoinard, P Champeroux, ... Clinical cancer research 12 (19), 5879-5886, 2006 | 99 | 2006 |
| Contrast enhanced magnetic resonance imaging underestimates residual disease following neoadjuvant docetaxel based chemotherapy for breast cancer F Denis, AV Desbiez-Bourcier, C Chapiron, F Arbion, G Body, ... European Journal of Surgical Oncology (EJSO) 30 (10), 1069-1076, 2004 | 99 | 2004 |
| Enhanced radiosensitivity of rat autochthonous mammary tumors by dietary docosahexaenoic acid S Colas, L Paon, F Denis, M Prat, P Louisot, C Hoinard, O Le Floch, ... International journal of cancer 109 (3), 449-454, 2004 | 82 | 2004 |
| What can be learned from a chaotic cancer model? C Letellier, F Denis, LA Aguirre Journal of theoretical biology 322, 7-16, 2013 | 69 | 2013 |
| Two-year survival comparing web-based symptom monitoring vs routine surveillance following treatment for lung cancer F Denis, E Basch, AL Septans, J Bennouna, T Urban, AC Dueck, ... Jama 321 (3), 306-307, 2019 | 63 | 2019 |
| In vivo quantitation of tumour vascularisation assessed by Doppler sonography in rat mammary tumours F Denis, P Bougnoux, L de Poncheville, M Prat, R Catroux, F Tranquart Ultrasound in medicine & biology 28 (4), 431-437, 2002 | 47 | 2002 |
| Phase II study of a radiotherapy total dose increase in hypoxic lesions identified by 18F-misonidazole PET/CT in patients with non–small cell lung carcinoma (RTEP5 study) P Vera, S Thureau, P Chaumet-Riffaud, R Modzelewski, P Bohn, ... Journal of Nuclear Medicine 58 (7), 1045-1053, 2017 | 43 | 2017 |
| Improving survival in patients treated for a lung cancer using self-evaluated symptoms reported through a web application F Denis, S Yossi, AL Septans, A Charron, E Voog, O Dupuis, G Ganem, ... American journal of clinical oncology 40 (5), 464-469, 2017 | 41 | 2017 |
| Detection of lung cancer relapse using self-reported symptoms transmitted via an internet web-application: pilot study of the sentinel follow-up F Denis, L Viger, A Charron, E Voog, O Dupuis, Y Pointreau, C Letellier Supportive Care in Cancer 22 (6), 1467-1473, 2014 | 38 | 2014 |
| Delineation in thoracic oncology: a prospective study of the effect of training on contour variability and dosimetric consequences S Dewas, JE Bibault, P Blanchard, C Vautravers-Dewas, Y Pointreau, ... Radiation Oncology 6 (1), 118, 2011 | 36 | 2011 |
| Overall survival in patients with lung cancer using a web-application-guided follow-up compared to standard modalities: Results of phase III randomized trial. F Denis, C Lethrosne, N Pourel, O Molinier, Y Pointreau, J Domont, ... Journal of Clinical Oncology 34 (18_suppl), LBA9006-LBA9006, 2016 | 34 | 2016 |
| Pemetrexed and carboplatin, an active option in first-line treatment of elderly patients with advanced non-small cell lung cancer (NSCLC): a phase II trial R Gervais, G Robinet, C Clément-Duchêne, F Denis, C El Kouri, P Martin, ... Lung Cancer 80 (2), 185-190, 2013 | 32 | 2013 |
| How tumor growth can be influenced by delayed interactions between cancer cells and the microenvironment? D Ghosh, S Khajanchi, S Mangiarotti, F Denis, SK Dana, C Letellier BioSystems 158, 17-30, 2017 | 31 | 2017 |
| 6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial X Pivot, G Romieu, M Debled, JY Pierga, P Kerbrat, T Bachelot, ... The Lancet 393 (10191), 2591-2598, 2019 | 29 | 2019 |
| Early assessment of metabolic response by 18F-FDG PET during concomitant radiochemotherapy of non–small cell lung carcinoma is associated with survival: a retrospective single … S Yossi, S Krhili, JP Muratet, AL Septans, L Campion, F Denis Clinical nuclear medicine 40 (4), e215-e221, 2015 | 27 | 2015 |
| Detecting lung cancer relapse using self-evaluation forms weekly filled at home: the sentinel follow-up F Denis, L Viger, A Charron, E Voog, C Letellier Supportive Care in Cancer 22 (1), 79-85, 2014 | 27 | 2014 |
